Biometrics Built Better

Veramed Solidifies Expansion in India with New Headquarters in Bengaluru

Share this article

Veramed is proud to announce the opening of its new India headquarters in Bengaluru, on 21 April 2025. This marks a significant step in the company’s ongoing expansion in the region.  Located in the heart of Bengaluru, the new headquarters will serve as a strategic base to further support Veramed’s global clients and partners while advancing the company’s ambitious growth objectives. The expanded office underscores Veramed’s commitment to building high-performing teams dedicated to quality and excellence. It will also act as a central hub for nurturing and developing local talent through Veramed’s industry-leading training and development programs.  The opening of Veramed’s new headquarters in India marks a major milestone in the company’s global growth journey, further strengthening its position as a leading specialist biometrics CRO. By adding local expertise and insights in India, Veramed is set to broaden its biometrics and data management capabilities, enhance operational efficiency, and deliver high-quality, tailored solutions to clients worldwide. This expansion reaffirms Veramed’s commitment to innovation, quality, and supporting the evolving needs of the pharmaceutical and biotech industries on a global scale.  

About Veramed

Veramed is a high-performing partner that provides a comprehensive suite of data management and biostatistical consulting services to a global client base. Their team is dedicated to accelerating evidence generation and advancing patient health by integrating people, innovation, and technology. They were awarded “Best Contract Research Organization – Specialist Providers” at the 18th Annual Scrip Awards in 2022 and has been certified as a B Corp™ organization twice (2020, 2024).

Veramed is passionate about making a difference in patient communities around the world. Being uniquely practitioner-led, the company challenges how advanced biometrics services can be used to help move the needle on the speed, quality, and effectiveness of pharma and biotech pipeline delivery.

Share this article

Stay Connected

Sign up to receive the latest insights, case studies, and Veramed news—straight to your inbox.

Related Posts